Exact Mass: 427.24495820000004
Exact Mass Matches: 427.24495820000004
Found 146 metabolites which its exact mass value is equals to given mass value 427.24495820000004
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Ranolazine
C24H33N3O4 (427.2470938000001)
Ranolazine is only found in individuals that have used or taken this drug. It is an antianginal medication. On January 31, 2006, ranolazine was approved for use in the United States by the FDA for the treatment of chronic angina. [Wikipedia]The mechanism of action of ranolazine is unknown. It does not increase the rate-pressure product, a measure of myocardial work, at maximal exercise. In vitro studies suggest that ranolazine is a P-gp inhibitor. Ranolazine is believed to have its effects via altering the trans-cellular late sodium current. It is by altering the intracellular sodium level that ranolazine affects the sodium-dependent calcium channels during myocardial ischemia. Thus, ranolazine indirectly prevents the calcium overload that causes cardiac ischemia. C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers C - Cardiovascular system > C01 - Cardiac therapy D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Dihydroxyacidissiminol
C25H33NO5 (427.23586080000007)
Dihydroxyacidissiminol is found in beverages. Dihydroxyacidissiminol is an alkaloid from fruits of Limonia acidissima (wood apple). Alkaloid from fruits of Limonia acidissima (wood apple). Dihydroxyacidissiminol is found in beverages and fruits.
Valyl-prolyl-glycyl-valyl-glycine
C19H33N5O6 (427.24307180000005)
Arachidonoyl ethanolamide phosphate
C22H38NO5P (427.24874680000005)
(1aS,2aS,5S,5aS,6S,6aR)-5-benzylhexahydro-2a-hydroxy-2-[(1E,4S,6S)-6-hydroxy-4-methyl-5-oxohept-1-enyl]-6,6a-dimethyl-3H-oxireno[f]isoindol-3-one|cytochalasin Z20
C25H33NO5 (427.23586080000007)
RANOLAZINE
C24H33N3O4 (427.2470938000001)
C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers C - Cardiovascular system > C01 - Cardiac therapy D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
(2R,2R,4aS,6R,8aS)-4-hydroxy-2,5,5,8a-tetramethyl-6-oxo-3,3,4,4a,5,6,6,7,7,8,8,8a-dodecahydro-2H-spiro[furo[2,3-e]isoindole-2,1-naphthalen]-6-yl acetate
C25H33NO5 (427.23586080000007)
Ala Ile Pro Gln
C19H33N5O6 (427.24307180000005)
Ala Ile Gln Pro
C19H33N5O6 (427.24307180000005)
Ala Leu Pro Gln
C19H33N5O6 (427.24307180000005)
Ala Leu Gln Pro
C19H33N5O6 (427.24307180000005)
Ala Pro Ile Gln
C19H33N5O6 (427.24307180000005)
Ala Pro Leu Gln
C19H33N5O6 (427.24307180000005)
Ala Pro Gln Ile
C19H33N5O6 (427.24307180000005)
Ala Pro Gln Leu
C19H33N5O6 (427.24307180000005)
Ala Gln Ile Pro
C19H33N5O6 (427.24307180000005)
Ala Gln Leu Pro
C19H33N5O6 (427.24307180000005)
Ala Gln Pro Ile
C19H33N5O6 (427.24307180000005)
Ala Gln Pro Leu
C19H33N5O6 (427.24307180000005)
Gly Pro Arg Val
Gly Pro Val Arg
Gly Arg Pro Val
Gly Arg Val Pro
Gly Val Pro Arg
Gly Val Arg Pro
Ile Ala Pro Gln
C19H33N5O6 (427.24307180000005)
Ile Ala Gln Pro
C19H33N5O6 (427.24307180000005)
Ile Pro Ala Gln
C19H33N5O6 (427.24307180000005)
Ile Pro Gln Ala
C19H33N5O6 (427.24307180000005)
Ile Gln Ala Pro
C19H33N5O6 (427.24307180000005)
Ile Gln Pro Ala
C19H33N5O6 (427.24307180000005)
Lys Pro Pro Ser
C19H33N5O6 (427.24307180000005)
Lys Pro Ser Pro
C19H33N5O6 (427.24307180000005)
Lys Ser Pro Pro
C19H33N5O6 (427.24307180000005)
Leu Ala Pro Gln
C19H33N5O6 (427.24307180000005)
Leu Ala Gln Pro
C19H33N5O6 (427.24307180000005)
Leu Pro Ala Gln
C19H33N5O6 (427.24307180000005)
Leu Pro Gln Ala
C19H33N5O6 (427.24307180000005)
Leu Gln Ala Pro
C19H33N5O6 (427.24307180000005)
Leu Gln Pro Ala
C19H33N5O6 (427.24307180000005)
Asn Pro Val Val
C19H33N5O6 (427.24307180000005)
Asn Val Pro Val
C19H33N5O6 (427.24307180000005)
Asn Val Val Pro
C19H33N5O6 (427.24307180000005)
Pro Ala Ile Gln
C19H33N5O6 (427.24307180000005)
Pro Ala Leu Gln
C19H33N5O6 (427.24307180000005)
Pro Ala Gln Ile
C19H33N5O6 (427.24307180000005)
Pro Ala Gln Leu
C19H33N5O6 (427.24307180000005)
Pro Gly Arg Val
Pro Gly Val Arg
Pro Ile Ala Gln
C19H33N5O6 (427.24307180000005)
Pro Ile Gln Ala
C19H33N5O6 (427.24307180000005)
Pro Lys Pro Ser
C19H33N5O6 (427.24307180000005)
Pro Lys Ser Pro
C19H33N5O6 (427.24307180000005)
Pro Leu Ala Gln
C19H33N5O6 (427.24307180000005)
Pro Leu Gln Ala
C19H33N5O6 (427.24307180000005)
Pro Asn Val Val
C19H33N5O6 (427.24307180000005)
Pro Pro Lys Ser
C19H33N5O6 (427.24307180000005)
Pro Pro Ser Lys
C19H33N5O6 (427.24307180000005)
Pro Gln Ala Ile
C19H33N5O6 (427.24307180000005)
Pro Gln Ala Leu
C19H33N5O6 (427.24307180000005)
Pro Gln Ile Ala
C19H33N5O6 (427.24307180000005)
Pro Gln Leu Ala
C19H33N5O6 (427.24307180000005)
Pro Arg Gly Val
Pro Arg Val Gly
Pro Ser Lys Pro
C19H33N5O6 (427.24307180000005)
Pro Ser Pro Lys
C19H33N5O6 (427.24307180000005)
Pro Val Gly Arg
Pro Val Asn Val
C19H33N5O6 (427.24307180000005)
Pro Val Arg Gly
Pro Val Val Asn
C19H33N5O6 (427.24307180000005)
Gln Ala Ile Pro
C19H33N5O6 (427.24307180000005)
Gln Ala Leu Pro
C19H33N5O6 (427.24307180000005)
Gln Ala Pro Ile
C19H33N5O6 (427.24307180000005)
Gln Ala Pro Leu
C19H33N5O6 (427.24307180000005)
Gln Ile Ala Pro
C19H33N5O6 (427.24307180000005)
Gln Ile Pro Ala
C19H33N5O6 (427.24307180000005)
Gln Leu Ala Pro
C19H33N5O6 (427.24307180000005)
Gln Leu Pro Ala
C19H33N5O6 (427.24307180000005)
Gln Pro Ala Ile
C19H33N5O6 (427.24307180000005)
Gln Pro Ala Leu
C19H33N5O6 (427.24307180000005)
Gln Pro Ile Ala
C19H33N5O6 (427.24307180000005)
Gln Pro Leu Ala
C19H33N5O6 (427.24307180000005)
Arg Gly Pro Val
Arg Gly Val Pro
Arg Pro Gly Val
Arg Pro Val Gly
Arg Val Gly Pro
Arg Val Pro Gly
Ser Lys Pro Pro
C19H33N5O6 (427.24307180000005)
Ser Pro Lys Pro
C19H33N5O6 (427.24307180000005)
Ser Pro Pro Lys
C19H33N5O6 (427.24307180000005)
Val Gly Pro Arg
Val Gly Arg Pro
Val Asn Pro Val
C19H33N5O6 (427.24307180000005)
Val Asn Val Pro
C19H33N5O6 (427.24307180000005)
Val Pro Gly Arg
Val Pro Asn Val
C19H33N5O6 (427.24307180000005)
Val Pro Arg Gly
Val Pro Val Asn
C19H33N5O6 (427.24307180000005)
Val Arg Gly Pro
Val Arg Pro Gly
Val Val Asn Pro
C19H33N5O6 (427.24307180000005)
Val Val Pro Asn
C19H33N5O6 (427.24307180000005)
Anandamide 0-phosphate
C22H38NO5P (427.24874680000005)
20-hydroxy N-Arachidonoyl Taurine
C22H37NO5S (427.23923120000006)
Dihydroxyacidissiminol
C25H33NO5 (427.23586080000007)
Anandamide O-phosphate
C22H38NO5P (427.24874680000005)
(-)-n-dodecyl-n-methylephedrinium bromide
C23H42BrNO (427.24495820000004)
bis[tris(dimethylamino)-λ5-phosphanylidene]azanium,tetrafluoroborate
C12H36BF4N7P2 (427.25364740000003)
Benzoic acid, 4-[[(5-ethoxy-5-oxopentyl)[2-(2-Methoxyphenyl)ethyl]aMino]Methyl]-, Methyl ester
C25H33NO5 (427.23586080000007)
Ivaltinostat
C24H33N3O4 (427.2470938000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
7-(4-Benzylpiperazin-1-yl)-3-(2-methoxyphenyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidine
(2S,3R)-2-[[4-(tert-butylcarbamoyl)piperazine-1-carbonyl]amino]-6-(diaminomethylideneamino)-3-formylhexanoic acid
[3-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methylsulfanyl]-8-azaniumyloctyl]azanium
C18H33N7O3S+2 (427.23654680000004)
4-[(4-Cyclohexyl-1-piperazinyl)-oxomethyl]-2-ethyl-6,7-dimethoxy-1-isoquinolinone
C24H33N3O4 (427.2470938000001)
N-(1-cyclohexyl-3-hydroxy-3,4-diphenylbutyl)benzamide
C29H33NO2 (427.25111580000004)
(2R,3R,3aS,9bS)-N-(cyclohexylmethyl)-1-(2-cyclopropyl-1-oxoethyl)-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C24H33N3O4 (427.2470938000001)
(2S,3S,3aR,9bR)-N-(cyclohexylmethyl)-1-(2-cyclopropyl-1-oxoethyl)-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C24H33N3O4 (427.2470938000001)
1-[(1S)-2-acetyl-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-1-butanone
C24H33N3O4 (427.2470938000001)
1-[(1R)-2-acetyl-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-1-butanone
C24H33N3O4 (427.2470938000001)
14-(Methoxycarbonyl)-4,4,8alpha,12,16-pentamethyl-3,17-dioxo-5beta,9beta,10alpha,13alpha-androsta-11,15-dien-15-olate
(1R,9S,10S,11S)-12-acetyl-N-(cyclohexylmethyl)-10-(hydroxymethyl)-6-oxo-5-[(Z)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C24H33N3O4 (427.2470938000001)
(1S,9R,10R,11R)-12-acetyl-N-(cyclohexylmethyl)-10-(hydroxymethyl)-6-oxo-5-[(Z)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C24H33N3O4 (427.2470938000001)
andrastin D(1-)
An enolate anion resulting from the deprotonation of the enol of andrastin D.Major species at pH 7.3. Published in http://dx.doi.org/10.1016/j.tet.2013.07.029
(1r,2s,4r,5s,8r,9e,11z,13e,15s,22s,23s,24s)-2,4,18-trihydroxy-9,15-dimethyl-25-oxa-17-azatetracyclo[20.2.1.0⁵,²⁴.0⁸,²³]pentacosa-6,9,11,13,17-pentaen-20-one
C25H33NO5 (427.23586080000007)
(3s,4s,6e)-7-[(1s,3as,4s,5s,7as)-1-benzyl-3,3a,5-trihydroxy-6,7-dimethyl-1,4,5,7a-tetrahydroisoindol-4-yl]-3-hydroxy-4-methylhept-6-en-2-one
C25H33NO5 (427.23586080000007)
(1s,2s,4s,4as,11ar,13as)-4-hydroxy-2-methyl-12-oxo-dodecahydroindeno[3a,3-i]indolizin-1-yl 2-(4-methoxyphenyl)acetate
C25H33NO5 (427.23586080000007)